How to prevent the trocar-site hernia? A totally atraumatic endoscopic mini-IPOM-Plug technique (with extra-lightweight titanium coated mesh and glue)
| ISRCTN | ISRCTN67377966 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN67377966 |
| Protocol serial number | N/A |
| Sponsor | Medical Cañada (Spain) |
| Funder | Universidad de Murcia |
- Submission date
- 16/11/2015
- Registration date
- 01/12/2015
- Last edited
- 16/11/2015
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Digestive System
Plain English summary of protocol
Background and study aims
Laparoscopy is a type of surgery that allows a surgeon to access the inside of the body without having to make large incisions in the skin. The arrival of laparoscopy could be regarded as the biggest change in surgical techniques this century. However, there is a negative side to this new approach, such as a new kind of hernia, the trocar-site hernia. A hernia is a weakness or split in the muscle wall of the abdomen which allows the abdominal contents (usually some part of the intestine) to bulge out. With the increasing use of laparoscopic surgery the problem of this new type of hernia will increase too. The surgical placement of a prophylactic (preventive) mesh may help to prevent trocar-site hernia. The aim of this study is to find out whether it is possible to prevent trocar-site hernia after laparoscopic cholecystectomy by placing a prophylactic mesh.
Who can participate?
Patients aged 20-70 undergoing laparoscopic cholecystectomy (gallbladder removal) for cholelitiasis (gallstones).
What does the study involve?
Patients are randomly allocated to either receive a prophylactic mesh or to not receive a mesh during their operation.
What are the possible benefits and risks of participating?
The patients who receive the mesh may be at risk of seroma (collection of fluid) or wound infection at the mesh site. The patients who do not receive the mesh may be at risk of hernia.
Where is the study run from?
La Vega Hospital (Spain).
When is the study starting and how long is it expected to run for?
January 2013 to December 2016.
Who is funding the study?
Universidad de Murcia (Spain).
Who is the main contact?
Prof Alfredo Moreno-Egea
moreno-egea@ono.com
Contact information
Scientific
Avda Primo de Rivera 7, 5ºD
Murcia
30008
Spain
| Phone | + 34(0) 639 66 21 13 |
|---|---|
| moreno-egea@ono.com |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | Prevention of the trocar-site hernia with prophylactic mesh: a randomized clinical trial |
| Study objectives | The trocar-site hernia is a new complication in laparoscopic surgery which is becoming increasingly prevalent. Thus, the search for an efficient method of prophylaxis should be prioritized. The aim of this study is to find out whether it is possible to prevent trocar-site hernia (umbilical site) after laparoscopic cholecystectomy using a prophylactic mesh. |
| Ethics approval(s) | Hospital General Universitario Morales Meseguer Ethics Committee, 01/01/2013 |
| Health condition(s) or problem(s) studied | Trocar-site hernia |
| Intervention | Patients were randomized on the day of surgery to receive either a prophylactic mesh in the umbilical trocar site (treatment group) or no treatment in the umbilical site (no treatment - control group). |
| Intervention type | Procedure/Surgery |
| Primary outcome measure(s) |
Recurrence rate at 1 year |
| Key secondary outcome measure(s) |
1. Operative time |
| Completion date | 30/12/2016 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | All |
| Target sample size at registration | 100 |
| Key inclusion criteria | 1. Patients undergoing surgery for symptomatic cholelitiasis 2. Age range 20-70 years 3. Male and female 4. American Society of Anesthesiology (ASA) classification of 3 or less 5. No co-morbidity cardiopulmonary, hepatic or renal impairment 6. Consent was given for surgery |
| Key exclusion criteria | 1. Patients with ASA higher than 3 2. Current malignant diseases 3. Proven mental illness or other circumstances that might compromise the patient’s cooperation in addition to those who refused to give informed consent |
| Date of first enrolment | 01/01/2015 |
| Date of final enrolment | 30/12/2016 |
Locations
Countries of recruitment
- Spain
Study participating centre
30008
Spain
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Data sharing statement to be made available at a later date |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
